Hidradenitis Suppurativa and Treatments
Hidradenitis Suppurativa and Treatments is a research topic within Dermatology. Science Explorer counts 6.4k research works in it since 1950. 18.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the treatment, pathogenesis, and comorbidities of Hidradenitis Suppurativa (HS), also known as Acne Inversa. It covers topics such as inflammatory pathways, genetic susceptibility, metabolic syndrome, and the impact of HS on quality of life. The cluster also discusses various therapeutic approaches including immunosuppressive therapy and TNF-alpha inhibitors.
- Hidradenitis Suppurativa
- Acne Inversa
- Inflammatory Pathways
- Tumour Necrosis Factor
- IL-17 Serum Levels
- Metabolic Syndrome
- Notch Signaling
- Genetic Susceptibility
- Quality of Life
- Immunosuppressive Therapy
- Research works
- 6.4k fractional, since 1950
- In the world top 10%
- 1.2k per year above
- Top-10% rate
- 18.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +86% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Hidradenitis Suppurativa and Treatments research?
By volume, the United States and China publish the most (665 and 145 works in 2022–2025).
By volume, 2022–2025
- 1 United States 665 works
- 2 China 145 works
- 3 Italy 102 works
- 4 Germany 91 works
- 5 Spain 82 works
- 6 Türkiye 74 works
- 7 United Kingdom 70 works
- 8 Canada 67 works
- 9 France 65 works
- 10 India 64 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Hidradenitis Suppurativa and Treatments research?
By volume in 2022–2025, University of Miami publishes the most Hidradenitis Suppurativa and Treatments research, followed by University of North Carolina at Chapel Hill and University of California, San Francisco.
By volume, 2022–2025
- 1 University of MiamiUnited States 16 works
- 2 University of North Carolina at Chapel HillUnited States 15 works
- 3 University of California, San FranciscoUnited States 13 works
- 4 Harvard UniversityUnited States 12 works
- 5 University of Alabama at BirminghamUnited States 11 works
- 6 University of TorontoCanada 11 works
- 7 Wake Forest UniversityUnited States 11 works
- 8 Wroclaw Medical UniversityPoland 10 works
- 9 University of CopenhagenDenmark 10 works
- 10 University of Naples Federico IIItaly 9 works
Where is Hidradenitis Suppurativa and Treatments research done?
The largest centres of Hidradenitis Suppurativa and Treatments research in 2022–2025 are New York (United States), Boston (United States), Toronto (Canada) and London (United Kingdom).
Largest cities, 2022–2025
- 1 New York United States 34 works
- 2 Boston United States 30 works
- 3 Toronto Canada 24 works
- 4 London United Kingdom 23 works
- 5 Los Angeles United States 23 works
- 6 Beijing China 22 works
- 7 Paris France 21 works
- 8 Copenhagen Denmark 19 works
- 9 Washington D.C. United States 19 works
- 10 Istanbul Türkiye 18 works
Where is the best place to study Hidradenitis Suppurativa and Treatments?
Among universities, judged by research, Wroclaw Medical University, University of Naples Federico II and University of California, San Francisco score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Wroclaw Medical UniversityPoland | 79.1 | 42.3% | 35.1× | 10 | +240.2% |
| 2 | University of Naples Federico IIItaly | 63.4 | 38.4% | 8.0× | 9 | +141.5% |
| 3 | University of California, San FranciscoUnited States | 58.4 | 14.9% | 10.2× | 13 | +153.1% |
| 4 | University of CopenhagenDenmark | 55.6 | 26.2% | 7.2× | 10 | +154.5% |
| 5 | Wake Forest UniversityUnited States | 54.3 | 14.8% | 22.4× | 11 | +216.7% |
| 6 | University of MiamiUnited States | 54.2 | 11.6% | 16.5× | 16 | +51.7% |
| 7 | Oregon Health & Science UniversityUnited States | 49.7 | 28.1% | 13.6× | 8 | — |
| 8 | Harvard UniversityUnited States | 46.3 | 22.3% | 5.0× | 12 | +133.7% |
| 9 | University of Alabama at BirminghamUnited States | 46.2 | 14.6% | 12.1× | 11 | — |
| 10 | Albert Einstein College of MedicineUnited States | 38.8 | 12.3% | 23.8× | 9 | — |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Hidradenitis Suppurativa and Treatments research growing?
Output in 2018–2022 was 86% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Hidradenitis Suppurativa and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.